Maternal influence in the transmission of asthma susceptibility

Edward G Barrett1

  • 1Respiratory Immunology and Asthma Program, Lovelace Respiratory Research Institute, Albuquerque, NM 87108, USA. tbarrett@lrri.org <tbarrett@lrri.org>

Insights

Maternal immune factors influence fetal development, potentially increasing a child's risk for asthma. Understanding this maternal influence may lead to new prevention strategies for allergic diseases.

Area of Science:

  • Pediatric Allergy and Immunology
  • Maternal-Fetal Immunology
  • Environmental Health

Background:

  • Asthma is a prevalent childhood chronic disease with rising rates.
  • Genetic and allergen exposures are known risk factors for asthma.
  • Maternal mediation of fetal-infant immune responses to allergens is increasingly recognized.

Purpose of the Study:

  • To elucidate the maternal role in fetal-infant immune development related to allergens.
  • To clarify the mechanisms linking maternal influence to allergic sensitization and asthma.
  • To identify potential targets for preventing allergic sensitization and asthma.

Main Methods:

  • Review of current evidence on maternal immune environment during pregnancy.
  • Analysis of immune system development in offspring exposed to maternal factors.
  • Investigation of the transition from Th2 to Th1 immune responses.

Main Results:

  • Maternal environment typically promotes a Th2-skewed fetal immune response.
  • A normal transition to a non-allergic Th1 response occurs post-birth.
  • Maternal allergic status may delay this transition, increasing asthma risk.

Conclusions:

  • Maternal immune factors significantly impact fetal-infant immune programming.
  • Delayed immune maturation in offspring is linked to increased allergy and asthma risk.
  • Further research into maternal-fetal immune interactions is crucial for developing preventive therapies.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...